Cargando…

Pathogenicity and virulence of Clostridium botulinum

Clostridium botulinum, a polyphyletic Gram-positive taxon of bacteria, is classified purely by their ability to produce botulinum neurotoxin (BoNT). BoNT is the primary virulence factor and the causative agent of botulism. A potentially fatal disease, botulism is classically characterized by a symme...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawson, Alexander M., Dempster, Andrew W., Humphreys, Christopher M., Minton, Nigel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171130/
https://www.ncbi.nlm.nih.gov/pubmed/37157163
http://dx.doi.org/10.1080/21505594.2023.2205251
_version_ 1785039362838233088
author Rawson, Alexander M.
Dempster, Andrew W.
Humphreys, Christopher M.
Minton, Nigel P.
author_facet Rawson, Alexander M.
Dempster, Andrew W.
Humphreys, Christopher M.
Minton, Nigel P.
author_sort Rawson, Alexander M.
collection PubMed
description Clostridium botulinum, a polyphyletic Gram-positive taxon of bacteria, is classified purely by their ability to produce botulinum neurotoxin (BoNT). BoNT is the primary virulence factor and the causative agent of botulism. A potentially fatal disease, botulism is classically characterized by a symmetrical descending flaccid paralysis, which is left untreated can lead to respiratory failure and death. Botulism cases are classified into three main forms dependent on the nature of intoxication; foodborne, wound and infant. The BoNT, regarded as the most potent biological substance known, is a zinc metalloprotease that specifically cleaves SNARE proteins at neuromuscular junctions, preventing exocytosis of neurotransmitters, leading to muscle paralysis. The BoNT is now used to treat numerous medical conditions caused by overactive or spastic muscles and is extensively used in the cosmetic industry due to its high specificity and the exceedingly small doses needed to exert long-lasting pharmacological effects. Additionally, the ability to form endospores is critical to the pathogenicity of the bacteria. Disease transmission is often facilitated via the metabolically dormant spores that are highly resistant to environment stresses, allowing persistence in the environment in unfavourable conditions. Infant and wound botulism infections are initiated upon germination of the spores into neurotoxin producing vegetative cells, whereas foodborne botulism is attributed to ingestion of preformed BoNT. C. botulinum is a saprophytic bacterium, thought to have evolved its potent neurotoxin to establish a source of nutrients by killing its host.
format Online
Article
Text
id pubmed-10171130
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-101711302023-05-11 Pathogenicity and virulence of Clostridium botulinum Rawson, Alexander M. Dempster, Andrew W. Humphreys, Christopher M. Minton, Nigel P. Virulence Review Article - Invited Clostridium botulinum, a polyphyletic Gram-positive taxon of bacteria, is classified purely by their ability to produce botulinum neurotoxin (BoNT). BoNT is the primary virulence factor and the causative agent of botulism. A potentially fatal disease, botulism is classically characterized by a symmetrical descending flaccid paralysis, which is left untreated can lead to respiratory failure and death. Botulism cases are classified into three main forms dependent on the nature of intoxication; foodborne, wound and infant. The BoNT, regarded as the most potent biological substance known, is a zinc metalloprotease that specifically cleaves SNARE proteins at neuromuscular junctions, preventing exocytosis of neurotransmitters, leading to muscle paralysis. The BoNT is now used to treat numerous medical conditions caused by overactive or spastic muscles and is extensively used in the cosmetic industry due to its high specificity and the exceedingly small doses needed to exert long-lasting pharmacological effects. Additionally, the ability to form endospores is critical to the pathogenicity of the bacteria. Disease transmission is often facilitated via the metabolically dormant spores that are highly resistant to environment stresses, allowing persistence in the environment in unfavourable conditions. Infant and wound botulism infections are initiated upon germination of the spores into neurotoxin producing vegetative cells, whereas foodborne botulism is attributed to ingestion of preformed BoNT. C. botulinum is a saprophytic bacterium, thought to have evolved its potent neurotoxin to establish a source of nutrients by killing its host. Taylor & Francis 2023-05-08 /pmc/articles/PMC10171130/ /pubmed/37157163 http://dx.doi.org/10.1080/21505594.2023.2205251 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Review Article - Invited
Rawson, Alexander M.
Dempster, Andrew W.
Humphreys, Christopher M.
Minton, Nigel P.
Pathogenicity and virulence of Clostridium botulinum
title Pathogenicity and virulence of Clostridium botulinum
title_full Pathogenicity and virulence of Clostridium botulinum
title_fullStr Pathogenicity and virulence of Clostridium botulinum
title_full_unstemmed Pathogenicity and virulence of Clostridium botulinum
title_short Pathogenicity and virulence of Clostridium botulinum
title_sort pathogenicity and virulence of clostridium botulinum
topic Review Article - Invited
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171130/
https://www.ncbi.nlm.nih.gov/pubmed/37157163
http://dx.doi.org/10.1080/21505594.2023.2205251
work_keys_str_mv AT rawsonalexanderm pathogenicityandvirulenceofclostridiumbotulinum
AT dempsterandreww pathogenicityandvirulenceofclostridiumbotulinum
AT humphreyschristopherm pathogenicityandvirulenceofclostridiumbotulinum
AT mintonnigelp pathogenicityandvirulenceofclostridiumbotulinum